Suscribe to our Newsletter

lunes, 20 de mayo de 2013

Call for Papers: Molecular Enzymology and Drug Targets


Call for Papers:

Molecular Enzymology and Drug Targets

Dear Dr / Prof.

I write to you in my role as Editor of “Molecular Enzymology and Drug Targets”

Enzymes received a bulk of research involving medicine, biotechnology, biochemistry, structural biology and many other specialties. Furthermore, it took the interest in many drug companies for development of new drugs. In spite of the great work done in the field of enzymes there no specific journal interested in enzymology and related areas of drug discovery. Therefore, the journal will be unique in its discipline as it can be the first interest to authors working in the field of enzymology and related subjects. MEDT publishes original articles, short communications, notes, and minireviews. Full length reviews are only published after invitation from the editorial board. Average first decision of submitted manuscript is expected to be 21 days.

I would like to invite you and/or your colleagues to submit an Original Research Article, Review, Short Report, Commentary or Case Report to be considered by peer-review for publication.

The published version of your article will be immediately placed in freely accessible full-text repositories. This complies with the NIH Public Access Policy and the Wellcome Trust Open Access Policy.

There are a number of benefits of submitting your research to the journal:

Rapid peer review and publication

The journal offers fast, thorough peer review and rapid publication, aiming to return a first decision within six weeks. We also publish all articles immediately upon acceptance, a service offered by few other publishers. On the day of acceptance articles will receive their final citation details. The accepted version of the manuscript will be replaced with a fully formatted PDF and XML version shortly thereafter.

Hybrid model

Authors have the option to choose the model for publishing their articles: under subscription (article processing charges: 100€) or open access (article processing charges: 300€). Articles published open access are immediately available online, for all to read, use and distribute without charge. Open access raises the visibility of your research, and a number of independent studies have found that research articles published in open access journals are twice as likely to be cited than those published in traditional, subscription journals.

High visibility among researchers in the field

Publishing in Molecular Enzymology and Drug Targets ensures high visibility for your work; Top-quality articles are accessed thousands of times over the course of a month across from the journal website

We look forward to receiving your next manuscript.

To enable the journal to make all of its content open access, Molecular Enzymology and Drug Targets levies an article-processing charge for each manuscript accepted after peer review (payable on acceptance). iMedPub offers various discounts on the article-processing charge, and if the submitting author's organization is a iMedPub Journals Member, the cost of the article processing charge is covered in full or in part by the membership.

Molecular Enzymology and Drug Targets is now accepting submissions. Submit your manuscript via our online submission system. For more information about the journal, contact

We are looking forward to hearing from you.

Kind regards,

Mahmoud Kandeel

The Headhunter 
Are you interested in medical publishing? Join us! social network Join now! Subscribe now!


No hay comentarios:

Publicar un comentario